ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

PMVP PMV Pharmaceuticals Inc

1,68
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 10:07:41
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
PMV Pharmaceuticals Inc PMVP NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 1,68 10:07:41
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,68
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
10.6.202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.6.202414:32EDGAR2Form 8-K - Current report
30.5.202413:00GLOBEPMV Pharmaceuticals to Participate at Upcoming Investor..
29.5.202413:00BWFoundation Medicine and PMV Pharma Announce Collaboration to..
09.5.202414:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.5.202414:00EDGAR2Form 8-K - Current report
09.5.202414:00GLOBEPMV Pharmaceuticals Reports First Quarter 2024 Financial..
27.3.202413:00GLOBEPMV Pharmaceuticals Announces First Patient Dosed in Global..
18.3.202421:01GLOBEPMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in..
29.2.202422:05EDGAR2Form 8-K - Current report
29.2.202422:01GLOBEPMV Pharmaceuticals Reports Full Year 2023 Financial Results..
26.2.202414:00GLOBEPMV Pharmaceuticals to Participate in the TD Cowen 44th..
24.1.202415:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
22.1.202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.1.202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.1.202422:02EDGAR2Form 8-K - Current report
18.1.202422:01GLOBEPMV Pharmaceuticals Announces Prioritization of PC14586..
11.1.202422:18EDGAR2Form 3 - Initial statement of beneficial ownership of..
05.1.202422:01EDGAR2Form 8-K - Current report
05.1.202422:01GLOBEPMV Pharmaceuticals Strengthens Leadership with Key..
09.11.202314:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202314:00EDGAR2Form 8-K - Current report
09.11.202314:00GLOBEPMV Pharmaceuticals Reports Third Quarter 2023 Financial..
12.10.202323:02EDGAR2Form 8-K - Current report
12.10.202318:30GLOBEPMV Pharmaceuticals Updated PC14586 Phase 1 Data..
11.10.202322:02EDGAR2Form 8-K - Current report
11.10.202318:00GLOBEPMV Pharmaceuticals to Present Updated Phase 1 Data on..
20.9.202322:05GLOBEPMV Pharmaceuticals to Present Updated Phase 1 Data on..
18.9.202322:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.9.202322:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.8.202314:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.8.202314:00EDGAR2Form 8-K - Current report
09.8.202314:00GLOBEPMV Pharmaceuticals Reports Second Quarter 2023 Financial..